Omnicell, Inc.
OMCL Nasdaq Electronic Computers Financials FY2016βFY2025
What Omnicell, Inc. does
No business description yet.
- Legal name
- OMNICELL, INC.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 26, 2026
- Accession Β· CIK
- 0000926326-26-000006
0000926326
Revenue and margins
Omnicell, Inc. had $1.2B of revenue in fiscal 2025, up 6.5% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew β18.8% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $86.9M in fiscal 2025, 7.3% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Omnicell, Inc. returned $77.6M to shareholders in fiscal 2025, 89% of free cash flow. The diluted share count rose 0.2%.
Balance sheet
Cash, debt and the ratios that show how comfortably Omnicell, Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $349M | $330M | $468M | $369M | $197M |
| Current ratio | 0.9x | 2.1x | 2.5x | 1.4x | 1.4x |
| Quick ratio | 0.8x | 1.7x | 2.2x | 1.2x | 1.2x |
| Total assets | $2.1B | $2.2B | $2.2B | $2.1B | $2.0B |
| Total liabilities | $996M | $1.1B | $1.0B | $878M | $743M |
| Shareholders' equity | $1.1B | $1.1B | $1.2B | $1.2B | $1.2B |
| Net debt (β = net cash) | β | β | β | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 4 / 9 | 8 / 9 | 7 / 9 | 4 / 8 | 6 / 8 | 6 / 8 | 4 / 8 | 5 / 8 | 6 / 8 |
| Accruals ratio | β4.3% | 0.6% | β6.3% | β7.2% | β10.0% | β7.8% | β3.3% | β9.1% | β8.1% | β6.1% |
| Altman Z'' | 2.40 | 2.80 | 3.82 | 4.65 | 3.82 | 1.76 | 3.01 | 3.29 | 2.76 | 3.07 |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $696M | $713M | $787M | $897M | $892M | $1.1B | $1.3B | $1.1B | $1.1B | $1.2B |
| Gross profit | $317M | $319M | $372M | $437M | $413M | $555M | $589M | $497M | $471M | $503M |
| Research and development | $57.8M | $66.0M | $64.8M | $68.6M | $70.2M | $75.7M | $105M | $97.1M | $90.4M | $88.7M |
| Operating income | $21.4M | $11.1M | $44.4M | $78.4M | $35.5M | $89.5M | β$2.3M | β$34.9M | $0.3M | $5.2M |
| Interest expense | $5.3M | $6.3M | $7.5M | $3.6M | β | β | β | β | β | β |
| Pretax income | $13.0M | $4.5M | $35.6M | $73.9M | $29.3M | $66.0M | β$2.5M | β$20.1M | $25.6M | $11.3M |
| Income tax | $3.2M | β$26.0M | β$2.1M | $12.6M | β$2.8M | β$11.8M | β$8.1M | $0.3M | $13.1M | $9.3M |
| Net income | $9.8M | $30.5M | $37.7M | $61.3M | $32.2M | $77.8M | $5.6M | β$20.4M | $12.5M | $2.1M |
| Diluted EPS | $0.26 | $0.79 | $0.93 | $1.43 | $0.74 | $1.62 | $0.12 | β$0.45 | $0.27 | $0.04 |
| Diluted shares | 0.04B | 0.04B | 0.04B | 0.04B | 0.04B | 0.05B | 0.05B | 0.05B | 0.05B | 0.05B |
| Cash flow | ||||||||||
| Cash from operations | $49.9M | $24.8M | $104M | $145M | $186M | $232M | $77.8M | $181M | $188M | $127M |
| Capital expenditure | $13.4M | $15.3M | $23.7M | $15.9M | $22.8M | $29.0M | $47.5M | $41.5M | $36.5M | $40.4M |
| Free cash flow | $36.5M | $9.5M | $80.3M | $129M | $163M | $203M | $30.2M | $140M | $151M | $86.9M |
| Depreciation and amortization | $58.4M | $51.5M | $51.4M | $53.6M | $61.1M | $73.0M | $86.9M | $87.3M | $82.2M | $78.8M |
| Stock-based compensation | $19.5M | $21.9M | $28.9M | $34.0M | $44.7M | $53.2M | $68.2M | $55.3M | $39.3M | $44.5M |
| Acquisitions | $312M | $4.4M | $0.0M | $0.0M | $225M | $354M | $3.4M | $0.0M | $0.0M | β |
| Share buybacks | $0.0M | $0.0M | $0.0M | $0.0M | $53.0M | $0.0M | $52.2M | $0.0M | $0.0M | $77.6M |
| Dividends and buybacks | $0.0M | $0.0M | $0.0M | $0.0M | $53.0M | $0.0M | $52.2M | $0.0M | $0.0M | $77.6M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $54.5M | $32.4M | $67.2M | $127M | $486M | $349M | $330M | $468M | $369M | $197M |
| Total debt | $254M | $210M | $140M | $50.0M | β | β | β | β | β | β |
| Current assets | $315M | $352M | $397M | $483M | $829M | $781M | $882M | $928M | $815M | $680M |
| Current liabilities | $181M | $205M | $205M | $237M | $276M | $876M | $428M | $368M | $596M | $477M |
| Inventory | $69.3M | $96.1M | $101M | $108M | $96.3M | $120M | $148M | $110M | $88.7M | $101M |
| Property and equipment, net | $42.0M | $42.6M | $51.5M | $54.2M | $59.1M | $71.1M | $94.0M | $109M | $113M | $120M |
| Goodwill | $328M | $338M | $336M | $337M | $499M | $739M | $734M | $736M | $735M | $738M |
| Intangible assets | $190M | $168M | $144M | $125M | $168M | $278M | $243M | $211M | $188M | $170M |
| Total assets | $935M | $1.0B | $1.1B | $1.2B | $1.8B | $2.1B | $2.2B | $2.2B | $2.1B | $2.0B |
| Total liabilities | $503M | $462M | $402M | $396M | $857M | $996M | $1.1B | $1.0B | $878M | $743M |
| Preferred stock | $0.0M | $0.0M | $0.0M | β | β | β | β | β | β | β |
| Shareholders' equity | $459M | $554M | $680M | $845M | $968M | $1.1B | $1.1B | $1.2B | $1.2B | $1.2B |
| Margins | ||||||||||
| Gross margin | 45.6% | 44.7% | 47.3% | 48.7% | 46.3% | 49.0% | 45.4% | 43.3% | 42.3% | 42.5% |
| Operating margin | 3.1% | 1.6% | 5.6% | 8.7% | 4.0% | 7.9% | β0.2% | β3.0% | 0.0% | 0.4% |
| EBITDA margin | 11.5% | 8.8% | 12.2% | 14.7% | 10.8% | 14.4% | 6.5% | 4.6% | 7.4% | 7.1% |
| Net margin | 1.4% | 4.3% | 4.8% | 6.8% | 3.6% | 6.9% | 0.4% | β1.8% | 1.1% | 0.2% |
| FCF margin | 5.2% | 1.3% | 10.2% | 14.4% | 18.3% | 17.9% | 2.3% | 12.2% | 13.6% | 7.3% |
| Returns | ||||||||||
| Return on capital | 2.4% | 1.5% | 5.9% | 8.5% | β | β | β | β | β | β |
| Return on capital employed | 2.8% | 1.4% | 5.1% | 7.8% | 2.3% | 7.1% | β0.1% | β1.9% | 0.0% | 0.3% |
| Return on equity | 2.1% | 6.0% | 6.1% | 8.0% | 3.6% | 7.4% | 0.5% | β1.8% | 1.0% | 0.2% |
| Return on assets | 1.0% | 3.1% | 3.6% | 5.3% | 2.1% | 3.9% | 0.3% | β0.9% | 0.6% | 0.1% |
| Return on tangible equity | β | 62.9% | 18.9% | 16.0% | 10.7% | 59.8% | 3.7% | β8.4% | 3.9% | 0.6% |
| Growth | ||||||||||
| Revenue growth | β | 2.4% | 10.5% | 13.9% | β0.5% | 26.9% | 14.5% | β11.5% | β3.0% | 6.5% |
| Net income growth | β | 212.8% | 23.6% | 62.6% | β47.5% | 141.8% | β92.7% | β460.7% | β | β83.6% |
| EPS growth | β | 203.8% | 17.7% | 53.8% | β48.3% | 118.9% | β92.6% | β475.0% | β | β85.2% |
| FCF growth | β | β74.0% | 745.6% | 60.9% | 26.3% | 24.4% | β85.1% | 361.6% | 8.3% | β42.6% |
| Share count change | β | 5.0% | 4.8% | 5.9% | 1.9% | 9.6% | β4.3% | β1.5% | 2.3% | 0.2% |
| Financial health | ||||||||||
| Net debt / EBITDA | 2.5x | 2.8x | 0.8x | β0.6x | β | β | β | β | β | β |
| Debt / equity | 0.6x | 0.4x | 0.2x | 0.1x | β | β | β | β | β | β |
| Interest coverage | 4.0x | 1.8x | 5.9x | 21.8x | β | β | β | β | β | β |
| Current ratio | 1.7x | 1.7x | 1.9x | 2.0x | 3.0x | 0.9x | 2.1x | 2.5x | 1.4x | 1.4x |
| Quick ratio | 1.4x | 1.2x | 1.4x | 1.6x | 2.7x | 0.8x | 1.7x | 2.2x | 1.2x | 1.2x |
| Capital allocation | ||||||||||
| Capex / revenue | 1.9% | 2.2% | 3.0% | 1.8% | 2.6% | 2.6% | 3.7% | 3.6% | 3.3% | 3.4% |
| Stock comp / revenue | 2.8% | 3.1% | 3.7% | 3.8% | 5.0% | 4.7% | 5.3% | 4.8% | 3.5% | 3.8% |
| Payouts / FCF | 0.0% | 0.0% | 0.0% | 0.0% | 32.5% | 0.0% | 172.6% | 0.0% | 0.0% | 89.3% |
| Quality scores | ||||||||||
| Piotroski F-score | β | 4.0 | 8.0 | 7.0 | 4.0 | 6.0 | 6.0 | 4.0 | 5.0 | 6.0 |
| Altman Z'' | 2.4 | 2.8 | 3.8 | 4.6 | 3.8 | 1.8 | 3.0 | 3.3 | 2.8 | 3.1 |
| Accruals ratio | β4.3% | 0.6% | β6.3% | β7.2% | β10.0% | β7.8% | β3.3% | β9.1% | β8.1% | β6.1% |
Source: SEC EDGAR XBRL filings (CIK 0000926326). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.